Wednesdays, 12 to 1 p.m.
BRaIN Program Seminar Series Spring 2023
Wednesdays, 4 to 5 p.m.
CORE Seminar Series Spring 2023
Mondays, 12 to 1 p.m.
CHHD Program Seminar Series Spring 2023
Thursdays, 4 to 5 p.m.
MeDiC Program Seminar Series Spring 2023
The first participants in this large study were recently selected at the Cedars Cancer Centre of the MUHC.
A passion to change the lives of cancer patients, young and old
Omani researcher Maha al-Riyami, PhD, studies underlying causes of type 1 diabetes and other autoimmune diseases
Marissa Fazio’s M.Sc. project aims to prevent health-care-associated...
A clearer understanding of how brain tumours originate during brain development is paving the way for improved therapies against pediatric high-grade gliomas, the leading cause of cancer-related...
Led by the Opal group at the RI-MUHC, the consortium has already made advances in data infrastructure and governance, as well as improving...
RI-MUHC researcher David P. Labbé and a team of international collaborators will investigate the mechanisms...
Dr. Thomas Hemmerling leads the development of an artificial intelligence-driven technology designed to...
RI-MUHC researcher aims to improve respiratory health of patients with lung infections
RI-MUHC researcher takes a leading role in several WHO initiatives
Felix Mathew wins the...
Trainees’ oral and poster presentations and a keynote lecture by Mark Andermann, PhD, were high points in the successful 2022 research event
Mondays, 9 to 10 a.m.
Meakins-Christie and RESP Program Seminar Series Spring 2023
Dr. Phil Gold recently received the McGill Medal
Presenter: Falisha Karpati, PhD
A new grant from the Canada Foundation for Innovation will invest in leading edge Containment Level 3...
— 25 Items per Page